The table below shows GeneDx Holdings Corp.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$427.54M
$305.45M
$202.57M
$234.69M
$212.19M
$179.32M
Cost of revenue
$129.37M
$111.05M
$112.56M
$261.44M
$228.80M
$175.30M
Gross profit
$298.17M
$194.40M
$90.01M
-$26.75M
-$16.60M
$4.03M
R&D
$72.03M
$45.72M
$58.27M
$86.20M
$105.16M
$72.70M
WGS annual revenue (10-K history)
GeneDx Holdings Corp. reported annual revenue of $427.54M for fiscal year 2025. That is up 40.0% from $305.45M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $196.17M (FY 2019) to $427.54M. Figures come from the company's audited annual reports as filed with the SEC.